| James Mckinney Iii, MD | |
|
2131 S 17th St, Wilmington, NC 28401-7407 | |
| (910) 815-5830 | |
| Not Available |
| Full Name | James Mckinney Iii |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 20 Years |
| Location | 2131 S 17th St, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174786859 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Columbus Regional Healthcare System | Whiteville, NC | Hospital |
| Pender Memorial Hospital | Burgaw, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Health Medical Group Coastal Region Llc | 2860809936 | 412 |
News Archive
Myriad Genetics, Inc., a global leader in personalized medicine, and ION Solutions, a part of AmerisourceBergen, and the largest physician services organization specializing in the support of community oncology, announced today that they have entered into a relationship to deliver quality hereditary cancer test results and services to ION member practices.
Beyond the morbidity and mortality associated with the pandemic, COVID-19 has paralyzed the global economy.
Phagenesis Ltd, the global leader in the treatment of dysphagia (inability to swallow safely) today announced that it has closed a €7 million Series B funding round designed to accelerate the company's development plans.
The evolution of the hepatitis B virus and its possible migration have become clearer with the sequencing of the oldest sample of the virus, isolated from a mummified 16th-century Korean child, say scientists.
New research in the Journal of Clinical Investigation reveals that tumours in melanoma patients deliberately create conditions that knock out the body's 'premier' immune defence and instead attract a weaker immune response unable to kill off the tumour's cancerous cells.
› Verified 7 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
Myriad Genetics, Inc., a global leader in personalized medicine, and ION Solutions, a part of AmerisourceBergen, and the largest physician services organization specializing in the support of community oncology, announced today that they have entered into a relationship to deliver quality hereditary cancer test results and services to ION member practices.
Beyond the morbidity and mortality associated with the pandemic, COVID-19 has paralyzed the global economy.
Phagenesis Ltd, the global leader in the treatment of dysphagia (inability to swallow safely) today announced that it has closed a €7 million Series B funding round designed to accelerate the company's development plans.
The evolution of the hepatitis B virus and its possible migration have become clearer with the sequencing of the oldest sample of the virus, isolated from a mummified 16th-century Korean child, say scientists.
New research in the Journal of Clinical Investigation reveals that tumours in melanoma patients deliberately create conditions that knock out the body's 'premier' immune defence and instead attract a weaker immune response unable to kill off the tumour's cancerous cells.
› Verified 7 days ago
| Entity Name | Novant Health Medical Group Coastal Region Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649865791 PECOS PAC ID: 2860809936 Enrollment ID: O20210408000285 |
News Archive
Myriad Genetics, Inc., a global leader in personalized medicine, and ION Solutions, a part of AmerisourceBergen, and the largest physician services organization specializing in the support of community oncology, announced today that they have entered into a relationship to deliver quality hereditary cancer test results and services to ION member practices.
Beyond the morbidity and mortality associated with the pandemic, COVID-19 has paralyzed the global economy.
Phagenesis Ltd, the global leader in the treatment of dysphagia (inability to swallow safely) today announced that it has closed a €7 million Series B funding round designed to accelerate the company's development plans.
The evolution of the hepatitis B virus and its possible migration have become clearer with the sequencing of the oldest sample of the virus, isolated from a mummified 16th-century Korean child, say scientists.
New research in the Journal of Clinical Investigation reveals that tumours in melanoma patients deliberately create conditions that knock out the body's 'premier' immune defence and instead attract a weaker immune response unable to kill off the tumour's cancerous cells.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Mckinney Iii, MD Po Box 936857, Atlanta, GA 31193-6857 Ph: () - | James Mckinney Iii, MD 2131 S 17th St, Wilmington, NC 28401-7407 Ph: (910) 815-5830 |
News Archive
Myriad Genetics, Inc., a global leader in personalized medicine, and ION Solutions, a part of AmerisourceBergen, and the largest physician services organization specializing in the support of community oncology, announced today that they have entered into a relationship to deliver quality hereditary cancer test results and services to ION member practices.
Beyond the morbidity and mortality associated with the pandemic, COVID-19 has paralyzed the global economy.
Phagenesis Ltd, the global leader in the treatment of dysphagia (inability to swallow safely) today announced that it has closed a €7 million Series B funding round designed to accelerate the company's development plans.
The evolution of the hepatitis B virus and its possible migration have become clearer with the sequencing of the oldest sample of the virus, isolated from a mummified 16th-century Korean child, say scientists.
New research in the Journal of Clinical Investigation reveals that tumours in melanoma patients deliberately create conditions that knock out the body's 'premier' immune defence and instead attract a weaker immune response unable to kill off the tumour's cancerous cells.
› Verified 7 days ago
Dr. Christopher Robert Myers, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3208 Oleander Dr, Wilmington, NC 28403 Phone: 910-794-3929 Fax: 910-798-2303 | |
Dr. Lionel Gregory Fernando, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5617 Maxwell Pl, Wilmington, NC 28409 Phone: 910-742-9243 Fax: 888-746-1787 | |
Nina Yokochi-funkhouser, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-815-5830 | |
Chih-cheng Frank Chen, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1608 Wellington Avenue, Wilmington Neurology Clinic, Wilmington, NC 28401 Phone: 910-395-5521 Fax: 910-350-1123 | |
Dr. Burt Powers Johnson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2023 S 17th St, Wilmington, NC 28401 Phone: 910-251-6499 Fax: 910-251-6511 | |
Dr. Brett A Gurkin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3208 Oleander Dr, Wilmington, NC 28403 Phone: 910-794-3929 Fax: 910-798-2303 | |
Karrie Elizabeth Grear, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1509 Doctors Cir, Bldg C, Wilmington, NC 28401 Phone: 910-662-7500 |